Neurati
- Biotech or pharma, therapeutic R&D
biotechnology company
Based in Montreal, Neurenati Therapeutics is a pioneering biotechnology company developing an innovative CURATIVE treatment for Hirschsprung disease.
With Maxime Ranger, serial entrepreneur, and various experts in medicine, gastroenterology, and rare disease clinical trials, the company is committed to bringing this treatment into clinical practice.
Neurenati Therapeutics aims to advance the first non-surgical therapy for Hirschsprung disease into clinical trials. This treatment has for objective to regenerate a functional enteric nervous system, to restore intestinal epithelial barrier permeability, to reduce inflammation, and to reestablish a healthy microbiota in young patients with Hirschsprung disease. The goal of this approach is to provide an alternative to surgery, the only available treatment for Hirschsprung disease available to date, and increase the well-being and quality of life of affected patients.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}